Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitis

Journal of Crohn's and Colitis

Volumn 1, Issue 1, 2007, Pages 21-27

  Eleftheriadis, N ^a   Lambrecht, G ^b   D'Haens, G ^c   Baert, F ^d   Cabooter, M ^e   Louis, E ^f   Assche, G Van ^g   Schurmans, P ^h   Caenepeel, P ⁱ   Outryve, M Van ^j   Lammens, P ^h   Gossum, A Van ^k   De Vos, M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Algemeen Ziekenhuis Damiaan Oostende   (Belgium)

^c IMELDA HOSPITAL   (Belgium)

^d Heilig Hart Ziekenhuis   (Belgium)

^e AZ Sint Jan Brugge Oostende AV   (Belgium)

^f UNIVERSITY OF LIÈGE   (Belgium)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h CAZ Hasselt ^*  (Belgium)

ⁱ DEPARTMENT OF CARDIOLOGY   (Belgium)

^j ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^k ERASME HOSPITAL   (Belgium)

more..

Author keywords

Corticosteroids; Extension of colitis; Immunosuppressives; Maintaining remission therapy; Mesalamine; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MESALAZINE;

ADULT; AGED; ARTICLE; BELGIUM; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG EFFICACY; EARLY DIAGNOSIS; ENDOSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; SMOKING; STATISTICAL ANALYSIS; TREATMENT DURATION; ULCERATIVE COLITIS;

EID: 37249031018     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2007.06.001     Document Type: Article

References (21)

1. Robinson M. Optimizing therapy for inflammatory bowel disease. Am J Gastroenterol 92 (1997) 12S-17S
2. Sachar D.B. Maintenance therapy in ulcerative colitis and Crohn's disease. J Clin Gastroenterol 20 (1995) 117-122
3. Ardizzone S., and Porro G.B. A practical guide to the management of distal ulcerative colitis. Drugs 55 (1998) 519-542
4. Schroeder K.W. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications. Scand J Gastroenterol Suppl (2002) 42-47
5. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group. Ann Intern Med 124 (1996) 204-211
6. Miner P., Hanauer S., Robinson M., Schwartz J., and Arora S. Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group. Dig Dis Sci 40 (1995) 296-304
7. Mulder C.J., Tytgat G.N., Weterman I.T., Dekker W., Blok P., Schrijver M., et al. Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology 95 (1988) 1449-1453
8. Paoluzi O.A., Pica R., Marcheggiano A., Crispino P., Iacopini F., Iannoni C., et al. Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission. Aliment Pharmacol Ther 16 (1902) 1751-1759
9. Fraser A.G., Morton D., McGovern D., Travis S., and Jewel D.P. The efficacy of methotrexate for maintaining remission in inflammatory bowel disease. Aliment Pharmacol Ther 16 (2002) 693-697
10. Fernandez-Banares F., Bertran X., Esteve-Comas M., Cabre E., Menacho M., Humbert P., et al. Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis. Am J Gastroenterol 91 (1996) 2498-2499
11. Langholz E., Munkholm P., Davidsen M., Nielsen O.H., and Binder V. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 31 (1996) 260-266
12. Langholz E., Munkholm P., Davidsen M., and Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 107 (1994) 3-11
13. Moum B., Ekbom A., Vatn M.H., and Elgjo K. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol 94 (1999) 1564-1569
14. Misiewicz J.J., Lennard-Jones J.E., Connell A.M., et al. Controlled trial of sulfasalazine in maintenance therapy for ulcerative colitis. Lancet 1 (1965) 185-188
15. Riley S.A., Mani V., Goodman M.J., Herd M.E., Dutt S., and Turnberg L.A. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology 94 (1988) 1383-1389
16. Rijk M.C., van Lier H.J., and van Tongeren J.H. Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: a prospective, double-blind, randomized multicenter study. The Ulcerative Colitis Multicenter Study Group. Am J Gastroenterol 87 (1992) 438-442
17. Marshall J.K., and Irvine E.J. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Am J Gastroenterol 95 (2000) 1628-1636
18. Sinclair T.S., Brunt P.W., and Mowat N.A. Nonspecific proctocolitis in northeastern Scotland: a community study. Gastroenterology 85 (1983) 1-11
19. Rubin D.T., and Hanauer S.B. Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol 12 (2000) 855-862
20. Russel M.G., and Stockbrugger R.W. Epidemiological developments and insights in chronic inflammatory bowel diseases. Ned Tijdschr Geneeskd 145 (2001) 1448-1452
21. Fooks L.J., and Gibson G.R. Probiotics as modulators of the gut flora. Br J Nutr 88 Suppl. 1 (2002) S39-S49